Simultaneous detection of the tumor suppressor FHIT gene and protein using the multi-functional biochip

Cancer Detection and Prevention

Volumn 26, Issue 5, 2002, Pages 331-342

  Askari, Minoo D F ^a   Miller, Gordon H ^b   Vo Dinh, Tuan ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b OAK RIDGE NATIONAL LABORATORY   (United States)

Author keywords

Biochip; Biosensors; Cancer diagnosis; FHIT; Fluorescence detection technology; Fragile histidine triad gene; Microarray technology; Tumor suppressor gene

Indexed keywords

ACID ANHYDRIDE HYDROLASES; CHROMOSOMES, HUMAN, PAIR 3; DNA, NEOPLASM; GENE EXPRESSION PROFILING; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OPTICS; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 12244289679     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-090X(02)00091-0     Document Type: Article

References (27)

1. Ohta M, Inoue H, Cotticelli MG, et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996:84(4):587-97.
2. 3-triphosphate hydrolase. Biochemistry 1996;35(36):11529-35.
3. Brenner C, Garrison P, Gilmour J, et al. Nat Struct Biol 1997;4:231-8.
4. Sard L, Accornero P, Tornielli S, et al. The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control. Proc Natl Acad Sci USA 1999;96(15):8489-92.
5. Huebner K, Garrison PN, Barnes LD, Croce CM. The role of the FHIT/FRA3B locus in cancer. Ann Rev Genet 1998;32:7-31.
6. Ingvarsson S, Agnarsson BA, Sigbjornsdottir BI, et al. Reduced FHIT expression in sporadic and BRCA2-linked breast carcinomas. Cancer Res 1999;59(11):2682-9.
7. Huiping C, Jonasson JG, Agnarsson BA, Sigbjornsdottir BI, Huebner K, Ingvarsson S. Analysis of the fragile histidine triad (FHIT) gene in lobular breast cancer. Eur J Cancer 2000;36(12):1552-7.
8. Mangray S, King TC. Molecular pathobiology of pancreatic adenocarcinoma. Front Biosci 1998;3:D1148-60.
9. Mueller J, Werner M, Siewert JR. Malignant progression in Barrett's esophagus: Pathology and molecular biology. Recent Results Cancer Res 2000;155:29-41.
10. Gartenhaus RB. Allelic loss determination in chronic lymphocytic leukemia by immunomagnetic bead sorting and microsatellite marker analysis. Oncogene 1997;14(3):375-8.
11. Sozzi G, Pastorino U, Moiraghi L, et al. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res 1998;58(22):5032-7.
12. Mori M, Mimori K, Shiraishi T, et al. Altered expression of FHIT in carcinoma and precarcinomatous lesions of the esophagus. Cancer Res 2000;60(5):1177-82.
13. Sozzi G, Musso K, Ratcliffe C, Goldstraw P, Pierotti MA, Pastorino U. Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: A prospect for early diagnosis. Clin Cancer Res 1999;5(10):2689-92.
14. Schultz S, Smith DR, Mock JJ, Schultz DA. Single-target molecule detection with nonbleaching multicolor optical immunolabels. Proc Natl Acad Sci USA 2000;97(3):996-1001.
15. Spiker JO, Kang KA. Preliminary study of real-time fiber optic based protein C biosensor. Biotechnol Bioeng 1999;66(3):158-63.
16. Narang U, Anderson GP, Ligler FS, Burans J. Fiber optic-based biosensor for ricin. J Biosens Bioelectron 1997;12(9/10):937-45.
17. Grant SA, Glass RS. Sol-gel-based biosensors for use in stroke treatment. IEEE Trans Biomed Eng 1999;46(10):1207-11.
18. Wadkins RM, Golden JP, Pritsiolas LM, Ligler FS. Detection of multiple toxic agents using a planar array immunosensor. Biosens Bioelectron 1998;13(3/4):407-15.
19. Vo-Dinh T, Wintenberg AL, Ericson MN, Isola N, Alarie JP. Development of a DNA biochip for gene diagnosis. In: Lieberman R, et al., editors. Biomedical Sensing and Imaging Technologies, SPIE Publishers, Bellingham, WA, 1998.
20. Vo-Dinh T, Alarie JP, Isola N, Landis D, Wintenberg AL, Ericson MN. DNA biochip using phototransitor integrated circuit. Anal Chem 1999;71(2):358-63.
21. Vo-Dinh T. Development of a DNA biochip: Principle and applications. Sens Actuators 1998;B(51):52-9.
22. Sozzi G, Musso K, Ratcliffe C, Goldstraw P, Pierotti MA, Pastorino U. Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: A prospect for early diagnosis. Clin Cancer Res 1999;5(10):2689-92.
23. Inaji H, Koyama H, Motomura K, et al. Simultaneous assay of ErbB-2 protein and carcinoembryonic antigen in cyst fluid as an aid in diagnosing cystic lesions of the breast. Breast Cancer 1994;1(1):25-30.
24. Sampietro G, Tomasic G, Collini P, et al. Gene product immunophenotyping of neuroendocrine lung tumors. No linking evidence between carcinoids and small-cell lung carcinomas suggested by multivariate statistical analysis. Appl Immunohistochem Mol Morphol 2000;8(1):49-56.
25. Satoh F, Umemura S, Osamura RY. Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and non-mammary tissue. Breast Cancer 2000;7(1):49-55.
26. Notohara K, Hamazaki S, Tsukayama C. Solid-pseudopapillary tumor of the pancreas: Immunohistochemical localization of neuroendocrine markers and CD10. Am J Surg Pathol 2000;24(10):1361-71.
27. Kanavaros P, Stefanaki K, Vlachonikolis J. Expression of p53, p21/waf1, bcl-2 bax, Rb and Ki67 proteins in Hodgkin's lymphomas. Histol Histopathol 2000;15(2):445-53.